IN2012DN00707A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00707A IN2012DN00707A IN707DEN2012A IN2012DN00707A IN 2012DN00707 A IN2012DN00707 A IN 2012DN00707A IN 707DEN2012 A IN707DEN2012 A IN 707DEN2012A IN 2012DN00707 A IN2012DN00707 A IN 2012DN00707A
- Authority
- IN
- India
- Prior art keywords
- biomarkers
- samples
- endometrial cancer
- compared
- differentially expressed
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 abstract 4
- 206010014733 Endometrial cancer Diseases 0.000 abstract 3
- 206010014759 Endometrial neoplasm Diseases 0.000 abstract 3
- 102100039217 3-ketoacyl-CoA thiolase, peroxisomal Human genes 0.000 abstract 1
- 102100034531 AP-1 complex subunit mu-2 Human genes 0.000 abstract 1
- 102100033473 Cingulin Human genes 0.000 abstract 1
- 102100040322 E3 ubiquitin-protein ligase RNF183 Human genes 0.000 abstract 1
- 102100028067 EGF-containing fibulin-like extracellular matrix protein 2 Human genes 0.000 abstract 1
- 102100035218 Epidermal growth factor receptor kinase substrate 8-like protein 2 Human genes 0.000 abstract 1
- 102100036725 Epithelial discoidin domain-containing receptor 1 Human genes 0.000 abstract 1
- 101710131668 Epithelial discoidin domain-containing receptor 1 Proteins 0.000 abstract 1
- 102100037789 FAST kinase domain-containing protein 1, mitochondrial Human genes 0.000 abstract 1
- 102100034265 GEM-interacting protein Human genes 0.000 abstract 1
- 101710102635 GEM-interacting protein Proteins 0.000 abstract 1
- 101000670146 Homo sapiens 3-ketoacyl-CoA thiolase, peroxisomal Proteins 0.000 abstract 1
- 101000924636 Homo sapiens AP-1 complex subunit mu-2 Proteins 0.000 abstract 1
- 101000944124 Homo sapiens Cingulin Proteins 0.000 abstract 1
- 101001104297 Homo sapiens E3 ubiquitin-protein ligase RNF183 Proteins 0.000 abstract 1
- 101001060248 Homo sapiens EGF-containing fibulin-like extracellular matrix protein 2 Proteins 0.000 abstract 1
- 101000876686 Homo sapiens Epidermal growth factor receptor kinase substrate 8-like protein 2 Proteins 0.000 abstract 1
- 101000878541 Homo sapiens FAST kinase domain-containing protein 1, mitochondrial Proteins 0.000 abstract 1
- 101100508538 Homo sapiens IKBKE gene Proteins 0.000 abstract 1
- 101001064427 Homo sapiens Liprin-beta-2 Proteins 0.000 abstract 1
- 101000616738 Homo sapiens NAD-dependent protein deacetylase sirtuin-6 Proteins 0.000 abstract 1
- 101001098179 Homo sapiens P2X purinoceptor 4 Proteins 0.000 abstract 1
- 101000731078 Homo sapiens Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Proteins 0.000 abstract 1
- 101001072202 Homo sapiens Protein disulfide-isomerase Proteins 0.000 abstract 1
- 101000712974 Homo sapiens Ras association domain-containing protein 7 Proteins 0.000 abstract 1
- 101000785517 Homo sapiens Tight junction protein ZO-3 Proteins 0.000 abstract 1
- 102100021857 Inhibitor of nuclear factor kappa-B kinase subunit epsilon Human genes 0.000 abstract 1
- 102100031981 Liprin-beta-2 Human genes 0.000 abstract 1
- 102100021840 NAD-dependent protein deacetylase sirtuin-6 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102100037601 P2X purinoceptor 4 Human genes 0.000 abstract 1
- 102100032391 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform Human genes 0.000 abstract 1
- 102100036352 Protein disulfide-isomerase Human genes 0.000 abstract 1
- 102100033241 Ras association domain-containing protein 7 Human genes 0.000 abstract 1
- -1 S0CS2 Proteins 0.000 abstract 1
- 101100189627 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PTC5 gene Proteins 0.000 abstract 1
- 101100082911 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ppp1 gene Proteins 0.000 abstract 1
- 102100026640 Tight junction protein ZO-3 Human genes 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 230000000875 corresponding effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 102220482253 tRNA pseudouridine synthase A_R16A_mutation Human genes 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09166398 | 2009-07-24 | ||
| PCT/EP2010/004550 WO2011009637A2 (fr) | 2009-07-24 | 2010-07-23 | Marqueurs de cancer endométrial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00707A true IN2012DN00707A (fr) | 2015-06-19 |
Family
ID=42751506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN707DEN2012 IN2012DN00707A (fr) | 2009-07-24 | 2010-07-23 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9046522B2 (fr) |
| EP (2) | EP2848700B1 (fr) |
| JP (1) | JP5934093B2 (fr) |
| KR (1) | KR101828290B1 (fr) |
| CN (2) | CN102549169B (fr) |
| AU (1) | AU2010275699B2 (fr) |
| BR (1) | BR112012001469B1 (fr) |
| CA (1) | CA2767914C (fr) |
| DK (1) | DK2456889T3 (fr) |
| ES (2) | ES2654340T3 (fr) |
| HR (1) | HRP20141062T1 (fr) |
| IN (1) | IN2012DN00707A (fr) |
| MX (1) | MX2012000921A (fr) |
| PL (1) | PL2456889T3 (fr) |
| PT (1) | PT2456889E (fr) |
| RU (1) | RU2596394C2 (fr) |
| WO (1) | WO2011009637A2 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN00707A (fr) * | 2009-07-24 | 2015-06-19 | Geadic Biotec Aie | |
| EP2758777B1 (fr) * | 2011-09-22 | 2018-02-07 | Memorial Sloan-Kettering Cancer Center | Détection du cancer de l'ovaire |
| EP2787350A1 (fr) * | 2013-04-05 | 2014-10-08 | Atlas Antibodies AB | ASRGL1 dans le cancer de l'endomètre |
| KR102113310B1 (ko) * | 2013-09-03 | 2020-05-20 | 아주대학교 산학협력단 | 암 세포 분리용 조성물, 키트 및 이를 이용한 분리 방법 |
| WO2016025332A1 (fr) | 2014-08-12 | 2016-02-18 | President And Fellows Of Harvard College | Système et procédé de surveillance de santé sur la base d'un fluide corporel collecté |
| US10435472B2 (en) * | 2014-09-17 | 2019-10-08 | Merck Patent Gmbh | Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases |
| CN107102141A (zh) * | 2016-02-23 | 2017-08-29 | 中国科学院生物物理研究所 | 分子标记物cd71及在子宫内膜癌诊断、分期及预后中的应用 |
| EP3442706A4 (fr) | 2016-04-13 | 2020-02-19 | NextGen Jane, Inc. | Dispositifs, systèmes et procédés de collecte et de conservation d'échantillon |
| FI3452829T3 (fi) * | 2016-05-04 | 2024-03-20 | Fundacio Hospital Univ Vall Dhebron Institut De Recerca | Perm endometriumsyövän markkerina |
| GB201702392D0 (en) * | 2017-02-14 | 2017-03-29 | Univ Edinburgh | Methods for cancer diagnosis using a gene expression signature |
| CN108732349A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Lta4h作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN108732351A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Eps8l2作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN108732350A (zh) * | 2017-04-20 | 2018-11-02 | 中国科学院上海生命科学研究院 | Pla2g6作为指示肝内结节及早期预警肝癌的生物标志物 |
| CN109085359A (zh) * | 2017-06-13 | 2018-12-25 | 中国医学科学院肿瘤医院 | 血清蛋白标志物组合在结直肠癌筛查和诊治中的应用 |
| EP3655778B1 (fr) * | 2017-07-21 | 2023-06-07 | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca | Agrin en tant que marqueur du cancer endometrial |
| CN109097462B (zh) * | 2018-09-10 | 2022-01-11 | 青岛市海慈医疗集团 | Ap1m2基因作为诊断青光眼的分子标志物的应用 |
| WO2020130190A1 (fr) * | 2018-12-20 | 2020-06-25 | 경상대학교병원 | Procédé de fourniture d'informations pour prédire ou diagnostiquer un risque de développer un cancer rénal |
| CN109797217A (zh) * | 2019-03-27 | 2019-05-24 | 河北医科大学第二医院 | 帕金森生物标志物及其在制备检测产品中的应用 |
| CN109811058B (zh) * | 2019-03-31 | 2021-11-12 | 青岛泱深生物医药有限公司 | 与宫颈疾病发生发展相关的生物标志物及其应用 |
| WO2022226381A1 (fr) * | 2021-04-22 | 2022-10-27 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Diagnostic pour prendre en charge une mise en correspondance d'essais cliniques et des analyses exploratoires de biomarqueurs chez les patients atteints de cancer |
| CN114317750B (zh) * | 2021-12-29 | 2024-05-14 | 上海市第十人民医院 | 一种卵巢癌生物标志物及其在制备用于卵巢癌腹水转移疾病的药物或试剂盒中的应用 |
| KR102584898B1 (ko) * | 2022-10-24 | 2023-10-04 | 연세대학교 산학협력단 | 자궁내막암 진단 방법 및 이를 이용한 키트 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| AUPO573697A0 (en) * | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| US7014996B1 (en) * | 1998-10-02 | 2006-03-21 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| AUPQ219799A0 (en) | 1999-08-13 | 1999-09-02 | R. Lurie Pty Ltd | Apparatus for obtaining potological samples |
| US6884578B2 (en) * | 2000-03-31 | 2005-04-26 | Affymetrix, Inc. | Genes differentially expressed in secretory versus proliferative endometrium |
| RU2232397C2 (ru) * | 2002-04-03 | 2004-07-10 | НИИ онкологии им. проф. Н.Н. Петрова | Способ ранней диагностики патологических состояний эндометрия |
| WO2004005891A2 (fr) * | 2002-07-10 | 2004-01-15 | The Regents Of The University Of Michigan | Profil d'expression du cancer du poumon |
| US7640114B2 (en) * | 2003-05-21 | 2009-12-29 | The Wistar Institute Of Anatomy & Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
| WO2005035746A2 (fr) | 2003-10-02 | 2005-04-21 | Xantos Biomedicine Ag | Usage medical de tbk-1 ou d'inhibiteurs de celui-ci |
| JP5629894B2 (ja) * | 2004-12-07 | 2014-11-26 | 国立大学法人大阪大学 | 甲状腺乳頭癌を診断するための新規のマーカー |
| JP5109131B2 (ja) | 2005-02-10 | 2012-12-26 | オンコセラピー・サイエンス株式会社 | 膀胱癌を診断する方法 |
| CN101304736A (zh) * | 2005-09-07 | 2008-11-12 | 雪兰诺实验室公司 | 治疗子宫内膜异位症的ikk抑制剂 |
| WO2007072220A2 (fr) * | 2005-09-12 | 2007-06-28 | Aurelium Biopharma Inc. | Jeu ordonne de microechantillons cible et methodes de diagnostic du cancer |
| NZ570008A (en) * | 2006-02-09 | 2011-10-28 | Univ South Florida | Detection of ovarian cancer by elevated levels of Bcl-2 in urine |
| US20070287158A1 (en) * | 2006-06-09 | 2007-12-13 | George Gorodeski | Cell collection and disease screening |
| EP1978106A1 (fr) * | 2007-04-07 | 2008-10-08 | Universitätsklinikum Hamburg-Eppendorf | Amplificateur ayant une protection de sortie, en particulier un amplificateur opérationnel pour une application audio |
| WO2008137591A2 (fr) | 2007-05-02 | 2008-11-13 | Biocept, Inc. | Détection non invasive d'un cancer de l'endomètre |
| JP5419195B2 (ja) * | 2007-08-03 | 2014-02-19 | 国立大学法人愛媛大学 | 頭頸部癌の腫瘍マーカー |
| US20110136123A1 (en) | 2007-08-15 | 2011-06-09 | Universite De Sherbrooke | Alternative splicing gene variants in cancer |
| US8053198B2 (en) | 2007-09-14 | 2011-11-08 | Meso Scale Technologies, Llc | Diagnostic methods |
| US20110028344A1 (en) | 2008-04-11 | 2011-02-03 | Expression Pathology, Inc. | Biomarkers for endometrial disease |
| IN2012DN00707A (fr) * | 2009-07-24 | 2015-06-19 | Geadic Biotec Aie |
-
2010
- 2010-07-23 IN IN707DEN2012 patent/IN2012DN00707A/en unknown
- 2010-07-23 PT PT107369902T patent/PT2456889E/pt unknown
- 2010-07-23 CN CN201080042678.6A patent/CN102549169B/zh active Active
- 2010-07-23 PL PL10736990T patent/PL2456889T3/pl unknown
- 2010-07-23 RU RU2012106432/10A patent/RU2596394C2/ru active
- 2010-07-23 BR BR112012001469-2A patent/BR112012001469B1/pt active IP Right Grant
- 2010-07-23 ES ES14183077.8T patent/ES2654340T3/es active Active
- 2010-07-23 US US13/386,536 patent/US9046522B2/en active Active
- 2010-07-23 DK DK10736990.2T patent/DK2456889T3/en active
- 2010-07-23 ES ES10736990.2T patent/ES2523683T3/es active Active
- 2010-07-23 JP JP2012520964A patent/JP5934093B2/ja active Active
- 2010-07-23 WO PCT/EP2010/004550 patent/WO2011009637A2/fr active Application Filing
- 2010-07-23 EP EP14183077.8A patent/EP2848700B1/fr active Active
- 2010-07-23 EP EP10736990.2A patent/EP2456889B1/fr active Active
- 2010-07-23 AU AU2010275699A patent/AU2010275699B2/en active Active
- 2010-07-23 KR KR1020127004840A patent/KR101828290B1/ko active IP Right Grant
- 2010-07-23 CN CN201510425228.XA patent/CN105132529A/zh active Pending
- 2010-07-23 MX MX2012000921A patent/MX2012000921A/es active IP Right Grant
- 2010-07-23 CA CA2767914A patent/CA2767914C/fr active Active
-
2014
- 2014-11-03 HR HRP20141062AT patent/HRP20141062T1/hr unknown
-
2015
- 2015-06-01 US US14/727,549 patent/US20150337392A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2456889E (pt) | 2014-11-21 |
| JP5934093B2 (ja) | 2016-06-15 |
| WO2011009637A2 (fr) | 2011-01-27 |
| CA2767914A1 (fr) | 2011-01-27 |
| US20150337392A1 (en) | 2015-11-26 |
| DK2456889T3 (en) | 2014-12-01 |
| CN102549169A (zh) | 2012-07-04 |
| CA2767914C (fr) | 2020-02-25 |
| MX2012000921A (es) | 2012-06-12 |
| HRP20141062T1 (hr) | 2015-01-02 |
| AU2010275699A1 (en) | 2012-02-02 |
| KR20120047334A (ko) | 2012-05-11 |
| EP2456889A2 (fr) | 2012-05-30 |
| ES2523683T3 (es) | 2014-11-28 |
| PL2456889T3 (pl) | 2015-02-27 |
| BR112012001469A2 (pt) | 2020-08-11 |
| ES2654340T3 (es) | 2018-02-13 |
| US9046522B2 (en) | 2015-06-02 |
| JP2013500001A (ja) | 2013-01-07 |
| AU2010275699B2 (en) | 2016-06-16 |
| RU2012106432A (ru) | 2013-08-27 |
| WO2011009637A3 (fr) | 2011-04-14 |
| EP2848700A1 (fr) | 2015-03-18 |
| RU2596394C2 (ru) | 2016-09-10 |
| EP2848700B1 (fr) | 2017-10-04 |
| CN102549169B (zh) | 2016-02-24 |
| CN105132529A (zh) | 2015-12-09 |
| KR101828290B1 (ko) | 2018-02-12 |
| BR112012001469B1 (pt) | 2021-08-10 |
| US20120122726A1 (en) | 2012-05-17 |
| EP2456889B1 (fr) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00707A (fr) | ||
| MY195999A (en) | Molecular Detection/Diagnosis Reagent for Tumor | |
| MY196078A (en) | Quinoline Derivatives As Tam Rtk Inhibitors | |
| WO2009019368A3 (fr) | Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal | |
| WO2009111643A3 (fr) | Marqueurs microrna pour la récurrence d’un cancer colorectal | |
| IN2012DN01403A (fr) | ||
| WO2010125566A3 (fr) | Marqueurs pour la détection d'un cancer | |
| IN2013CN01129A (fr) | ||
| WO2013033609A3 (fr) | Méthodes et compositions pour le traitement et le diagnostic du cancer | |
| WO2011079902A3 (fr) | Matériaux biologiques et utilisations de ceux-ci | |
| WO2008117314A3 (fr) | Variants génétiques du chr2 et chr16 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
| WO2006133923A3 (fr) | Diagnostic, pronostic, et prediction de la recurrence des cancers du sein | |
| WO2014057357A3 (fr) | Méthode pour le diagnostic, le pronostic et le traitement d'une métastase du cancer de la prostate | |
| WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
| TR201907389T4 (tr) | Meme kanserinden kaynaklanan metastazlı kemik kanserinin prognozu ve tedavisine yönelik yöntem. | |
| WO2011015944A3 (fr) | Utilisation d'adn libre en tant que prédicteur précoce de la gravité d'une pancréatite aiguë | |
| WO2013172779A3 (fr) | Procédé pour indiquer la présence ou non-présence de cancer de la prostate | |
| NZ722492A (en) | Specific biomarker set for non-invasive diagnosis of liver cancer | |
| CA2817701C (fr) | Nouveau marqueur pour la detection du cancer de la vessie et/ou de conditions inflammatoires de la vessie | |
| WO2009019367A3 (fr) | Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal | |
| WO2009074328A3 (fr) | Methodes et acides nucleiques permettant d'analyser les troubles de la proliferation cellulaire | |
| MX2013011431A (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| WO2009153774A3 (fr) | Compositions et procédés pour le pronostic du cancer des ovaires | |
| WO2011143575A3 (fr) | Smfret avec des protéines membranaires | |
| IN2012DN05143A (fr) |